RNS Number:1107V
Proximagen Neuroscience Plc
18 April 2007
Proximagen Neuroscience plc
(the "Company")
Additional Listing
The Company announces that following the exercise of 10,500 options, it has
issued and allotted 10,500 Ordinary Shares of 1p each ("Ordinary Shares")
representing approximately 0.05 per cent. of its enlarged issued ordinary
share
capital.
Application has been made to the London Stock Exchange for these shares to
be
admitted to trading on AIM, and it is expected that Admission will become
effective, and that dealings will commence, on 24 April 2007.
18 April 2007
For further information please contact:
Proximagen Neuroscience plc
Kenneth Mulvany, Chief Executive Officer
James Hunter, Finance Director
020 7848 6011
